THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

China Universal Asset Management Co., Ltd.'s Holding History (CIK: 0001906594)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 8,257 Value ($000) $154 Avg Close $16.59 Range $13.50 - $20.33
Q3 2025
Shares 8,828 Value ($000) $129 Avg Close $12.64 Range $10.82 - $14.87
Q2 2025
Shares 10,043 Value ($000) $111 Avg Close $9.72 Range $7.90 - $11.82
Q1 2025
Shares 9,864 Value ($000) $88 Avg Close $9.31 Range $8.35 - $10.90
Q4 2024
Shares 10,427 Value ($000) $98 Avg Close $9.10 Range $7.88 - $10.26
Q3 2024
Shares 9,409 Value ($000) $76 Avg Close $8.66 Range $7.44 - $10.42
Q2 2024
Shares 5,713 Value ($000) $48 Avg Close $9.03 Range $8.13 - $10.44
Q1 2024
Shares 9,583 Value ($000) $86 Avg Close $9.27 Range $8.21 - $11.71
Q4 2023
Shares 5,759 Value ($000) $65 Avg Close $10.06 Range $8.52 - $11.57
Q3 2023
Shares 1,357 Value ($000) $12 Avg Close $9.65 Range $8.25 - $10.59
Q2 2023
Shares 757 Value ($000) $8 Avg Close $11.04 Range $9.98 - $12.03
Q1 2023
Shares 913 Value ($000) $10 Avg Close $10.57 Range $9.25 - $11.52
Q4 2022
Shares 684 Value ($000) $8 Avg Close $10.51 Range $9.56 - $11.83
Q3 2022
Shares 716 Value ($000) $7 Avg Close $9.37 Range $7.53 - $11.00